Skip to content

Romosozumab

Also known as Evenity (us)

Bone & Joint
Save $23,105/mo
4× cheaper

Romosozumab-aqqg injection is used to treat osteoporosis (condition in which the bones become thin and weak and break easily) in postmenopausal women (women who have experienced a change of life; end of menstrual periods) who have a high risk of a fracture or when other osteoporosis treatments did not help or could not be tolerated.

United States
$30,789
per month
India
$7,684
per month
You save
$23,105
75% cheaper in India
37.4K US scripts/yr$865.1M potential annual savings$1.2B US spend/yr
Compare the price
US price$30,789per month
India price$7,684per month
You save$23,10575% less

Based on 30 units per month. US $1,026.29 vs India $256.12 per unit.

Total over 1 periodSave $23,105$30,789$7,684
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$138,631
Estimated travel cost
− $2,300
Net savings after travel
$136,331

Even after travel, you could come out ahead by about $136,331.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Romosozumab is filled about 37.4K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$1.2B
If sourced from India
$287.7M
Potential annual savings
$865.1M
75%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.